Quantifying work function differences using low-energy electron microscopy: The case of mixed-terminated strontium titanate von Jobst, Johannes, Boers, Laurens M., Yin, Chunhai, Aarts, Jan, Tromp, Rudolf M., van der Molen, Sense Jan

Volltext

Quantifying work function differences using low-energy electron microscopy: the case of mixed-terminated strontium titanate von Jobst, Johannes, Boers, Laurens M, Yin, Chunhai, Aarts, Jan, Tromp, Rudolf M, Sense Jan van der Molen

Volltext

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma von ter Maat, Laurens S., van Duin, Isabella A.J., Elias, Sjoerd G., Leiner, Tim, Verhoeff, Joost J.C., Arntz, Eran R.A.N., Troenokarso, Max F., Blokx, Willeke A.M., Isgum, Ivana, de Wit, Geraldine A., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., Boomsma, Martijn F., van den Eertwegh, Fons J.M., de Groot, Jan Willem B., Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M., Kapiteijn, Ellen, van Diest, Paul J., Pluim, Josien P.W., de Jong, Pim A., Suijkerbuijk, Karijn P.M., Veta, Mitko

Volltext

Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma von Ter Maat, Laurens S., De Mooij, Rob A. J., Van Duin, Isabella A. J., Verhoeff, Joost J. C., Elias, Sjoerd G., Leiner, Tim, van Amsterdam, Wouter A. C., Troenokarso, Max F., Arntz, Eran R. A. N., Van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., Boomsma, Martijn F., Van den Eertwegh, Fons J. M., de Groot, Jan Willem, Hospers, Geke A. P., Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M., Kapiteijn, Ellen, De Wit, Ardine A., Blokx, Willeke A. M., Van Diest, Paul J., De Jong, Pim A., Pluim, Josien P. W., Suijkerbuijk, Karijn P. M., Veta, Mitko

Volltext

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma von van Duin, Isabella A.J., Schuiveling, Mark, ter Maat, Laurens S., van Amsterdam, Wouter A.C., van den Berkmortel, Franchette, Boers-Sonderen, Marye, de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Labots, Mariette, Piersma, Djura, Schrader, Anne M.R., Vreugdenhil, Gerard, Westgeest, Hans, Veta, Mitko, Blokx, Willeke A.M., van Diest, Paul J., Suijkerbuijk, Karijn P.M.

Volltext

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first‐line treatment of patients with advanced HER... von Meulendijks, Didier, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E.A., Goey, Swan H., de Jong, Robert S., Vanhoutvin, Steven A.L.W., Kuiper, Maria, Sikorska, Karolina, Pluim, Dick, Beijnen, Jos H., Schellens, Jan H.M., Grootscholten, Cecile, Tesselaar, Margot E.T., Cats, Annemieke

Volltext

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study von Meulendijks, Didier, Beerepoot, Laurens V., Boot, Henk, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Vanhoutvin, Steven A. L. W., Polee, Marco B., Beeker, Aart, Portielje, Johanna E. A., de Jong, Robert S., Goey, Swan H., Kuiper, Maria, Sikorska, Karolina, Beijnen, Jos H., Tesselaar, Margot E., Schellens, Jan H. M., Cats, Annemieke

Volltext

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma von Ter Maat, Laurens S, van Duin, Isabella A J, Elias, Sjoerd G, Leiner, Tim, Verhoeff, Joost J C, Arntz, Eran R A N, Troenokarso, Max F, Blokx, Willeke A M, Isgum, Ivana, de Wit, Geraldine A, van den Berkmortel, Franchette W P J, Boers-Sonderen, Marye J, Boomsma, Martijn F, van den Eertwegh, Fons J M, de Groot, Jan Willem B, Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M, Kapiteijn, Ellen, van Diest, Paul J, Pluim, Josien P W, de Jong, Pim A, Suijkerbuijk, Karijn P M, Veta, Mitko

Volltext

How do adolescents with cerebral palsy participate? Learning from their personal experiences von Wintels, Sophie Catharina, Smits, Dirk‐Wouter, Wesel, Floryt, Verheijden, Johannes, Ketelaar, Marjolijn, Leest, Anna, Groot, Coosje, Snel, Dion, Water, Jesse, Sluiter, Lauren, Bruijn, Nando, Janssen, Nathan, Makkreel, Nienke Heijne, Kramer, Nikita, Bouma, Piotr, Vergeer, Sam, Boer, Thom, Voorman, J.M., Dallmeijer, A.J., Roebroeck, M.E., Reinders‐Messelink, H.A., Gorter, J.W.

Volltext

Mathematical 3D Liver Model for Surgical versus Ablative Therapy Treatment Planning for Colorectal Liver Metastases: Recommendations from the COLLISION and COLDFIRE Trial Expert Pa... von van den Bemd, Bente A T, Puijk, Robbert S, Keijzers, Han, van den Tol, Petrousjka M, Meijerink, Martijn R

Volltext

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER... von Meulendijks, Didier, De Groot, Jan Willem B, Los, Maartje, Boers, James E, Beerepoot, Laurens V, Polee, Marco B, Beeker, Aart, Portielje, Johanna E A, Goey, Swan H, De Jong, Robert S, Vanhoutvin, Steven A L W, Kuiper, Maria, Sikorska, Karolina, Pluim, Dick, Beijnen, Jos H, Schellens, Jan H M, Grootscholten, Cecile, Tesselaar, Margot E T, Cats, Annemieke

Volltext

Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study von de Veer, Rozanne C., van Hooff, Maria C.B., Werner, Ellen, Beuers, Ulrich, Drenth, Joost P.H., Cuperus, Frans J.C., van Hoek, Bart, Veldt, Bart J., Klemt-Kropp, Michael, van Meer, Suzanne, Verdonk, Robert C., Flink, Hajo J., Vrolijk, Jan Maarten, Gevers, Tom J.G., Ponsioen, Cyriel Y., ter Borg, Martijn J., Soufidi, Khalida, Boersma, Femke, de Jonge, Hendrik J.M., Wolfhagen, Frank H.J., Baak, L.C., Onderwater, Susanne L., van Putten, Paul G., de Bruin, Gijs J., Adang, Rob P.R., de Boer, Wink, Borg, Frank ter, van Soest, Hanneke, Janssen, Harry L.A., Erler, Nicole S., van der Meer, Adriaan J., Abraham, Sunje, Aktas, Huseyin, Alderlieste, Yasser A., Aparicio-Pages, Maria N., Baven-Pronk, Martine A.M.C., van der Beek, A. (Sander), Bekkering, Frank C., Beuers, Ulrich, Beukema, Menno, de Boer, Wink, Boersma, Femke, Boonstra, Kirsten, ter Borg, Frank, ter Borg, Martijn J., ter Borg, Pieter C.J., de Bruin, Gijs J., Bus, Paul J., Cazemier, Marcel, Cuperus, Frans J.C., van Dam, Lisette J.H., Denters, Maaike J., Drenth, Joost P.H., Epping, Ludger S.M., Erler, Nicole S., Friederich, Philip W., van Gerven, Nicole F.M., Gevers, Tom J.G., Hansen, Bettina E., van den Hazel, Sven J., van Hoek, Bart, van Hooff, Maria C., Hotho, Daphne M., Janssen, Harry L.A., de Jonge, Hendrik J.M., Kemenade, J.(Netty) van, Kerbert-Dreteler, Marjo J., Klemt-Kropp, Michael, Konings, Ingrid C.A.W., de Kort, Sander, Kuiper, Edith M.M., Kuyvenhoven, Johan P.H., van der Meer, Adriaan J., van Meer, Suzanne, Onderwater, Susanne L., Oterdoom, Leendert H., Ponsioen, Cyriel Y., van Putten, Paul G., van Rooij, Janne E., Roomer, Robert, Schmidt-Böhmer, Johannes, Schmittgens, Stephan, Schreuder, Tim C.M.A., Nicolaas, Jerome Sint, van Soest, Hanneke, Soufidi, Khalida, van Stiphout, Stephan H.C., Thio, Hans H.K., Tielemans, Merel M., Vandebosch, Sigrid, de Veer, Rozanne C., Veldt, Bart J., Verdonk, Robert C., Marleen de Vree, J., de Vries, Elsemieke, Vrieze, Anne, Vrolijk, Jan Maarten, van der Waaij, Laurens A., de Wit, Ulrike, Wolfhagen, Frank H.J.

Volltext

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study von Meulendijks, Didier, Beerepoot, Laurens V, Boot, Henk, de Groot, Jan Willem B, Los, Maartje, Boers, James E, Vanhoutvin, Steven A L W, Polee, Marco B, Beeker, Aart, Portielje, Johanna E A, de Jong, Robert S, Goey, Swan H, Kuiper, Maria, Sikorska, Karolina, Beijnen, Jos H, Tesselaar, Margot E, Schellens, Jan H M, Cats, Annemieke

Volltext